Target RWE: Acquires NoviSci

  • Target RWE, a Durham, NC-based real-world evidence (RWE) solutions company for the pharmaceutical and biotech industries, acquired NoviSci, Inc.
  • The amount of the deal not disclosed
  • The acquisition broadens Target RWE’s data analytics capabilities and will also enable the company to meet the demand for high-quality evidence from real-world data
  • The company has built a novel repository of rigorously developed interactive real-world studies that can also adapted to new datasets and populations
  • Target RWE designs custom data sets, analyses, and evidence to address the complexities of healthcare evidence questions and quality initiatives
  • Target RWE has developed a turnkey health evidence solution which rapidly aggregates real-world data (RWD) from a large network of participating sites
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

LSEG Launches Blockchain-Based Digital Settlement Network

This new platform aims to enhance financial settlement processes.Highlights: LSEG has launched a blockchain-enabled digital settlement network.The platform...

SWIFT to Build Shared Ledger for Tokenised Asset Transactions

New initiative aims to streamline digital asset transactions globally.Highlights: SWIFT is launching a shared ledger for tokenised assets.The...

Keye Launches AI Co-Pilot for Private Equity Due Diligence

Innovative tool aims to streamline investment analysis and decision-making.Highlights: Keye introduces an AI co-pilot for private equity due...

Cosegic Strengthens Financial Crime Expertise with Fintrail Acquisition

The acquisition enhances Cosegic's capabilities in combating financial crime.Highlights: Cosegic acquires Fintrail to enhance financial crime capabilities.The acquisition...